Skip Navigation
Skip to contents

Journal of Microbiology : Journal of Microbiology

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
3 "oral microbiome"
Filter
Filter
Article category
Keywords
Publication year
Authors
Full article
Microbial signatures in oral sites of patients with primary Sjögren’s syndrome: Association with salivary gland hypofunction
Sarah Kamounah, Arjun Sarathi, Christiane Elisabeth Sørensen, Manimozhiyan Arumugam, Anne Marie Lynge Pedersen
J. Microbiol. 2025;63(6):e2501030.   Published online June 30, 2025
DOI: https://doi.org/10.71150/jm.2501030
  • 1,591 View
  • 50 Download
AbstractAbstract PDFSupplementary Material

This study aimed to determine if the microbiota in four different oral sites and the oral health status differ between patients with primary Sjögren’s syndrome (pSS), non-pSS sicca symptoms, and healthy controls. All participants underwent an interview and clinical oral examination. Stimulated whole saliva (SWS), supragingival plaque (SGP), buccal mucosa tissue (BLM), and tongue scrape (TGS) samples from 23 pSS patients, 36 patients with sicca symptoms, not fulfilling the classification criteria for pSS (non-pSS sicca), and 21 age-matched healthy controls (HC) were analyzed using V3–V4 16S rRNA gene amplicon sequencing, and determination of amplicon sequence variants (ASVs). PSS and non-pSS sicca patients did not differ with respect to oral health status, saliva flow rates, abundance of predominant genera, relative abundance on genus level or bacterial diversity in any of the oral sites. Both patient groups differed significantly from the healthy control group in the abundance of 61 ASVs across all sites. The alpha-diversity was lower in SGP from non-pSS sicca patients (p = 0.019), and in TGS from pSS patients (p = 0.04). The proportion of variation in the beta-diversity across all four sites could be explained by the diagnosis (pSS, non-pSS sicca, and HC). However, subgrouping of patients according to their stimulated salivary flow rates (SWS > 0.7 ml/min versus SWS ≤ 0.7 ml/min), revealed significantly different abundance of three ASVs in SWS, 11 in SGP, and six in TGS. Our findings suggest that hyposalivation rather than pSS itself modifies the microbial composition in oral site-specific patterns leading to oral diseases.

Journal Article
Description of Streptococcus dentalis sp. nov., Streptococcus gingivalis sp. nov., and Streptococcus lingualis sp. nov., Isolated from Human Oral Cavities
Beom-Jin Goo, Young-Sik Choi, Do-Hun Gim, Su-Won Jeong, Jee-Won Choi, Hojun Sung, Jae-Yun Lee, Jin-Woo Bae
J. Microbiol. 2024;62(11):973-983.   Published online November 12, 2024
DOI: https://doi.org/10.1007/s12275-024-00178-1
  • 282 View
  • 8 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract PDF
We isolated three novel strains, S1T, S2T, and S5T, from human oral cavities and identified them as distinct novel species. All these strains are facultatively anaerobic, Gram-stain-positive, and non-flagellated bacteria. Their optimal growth conditions for these strains were observed in Columbia broth (CB) at 37 °C, pH 7.0, and in the absence of NaCl. Phylogenetic analyses, employing the 16S rRNA gene and whole-genome sequencing, confirmed that all three strains belong to the genus Streptococcus. The 16S rRNA gene sequences of strains S1T, S2T, and S5T showed the highest similarities to Streptococcus parasanguinis, 98.57%, 99.05%, and 99.05%, respectively, and the orthologous average nucleotide identity (OrthoANI) values between the three strains and S. parasanguinis were 93.82%, 93.67%, and 94.04%, respectively. The pairwise OrthoANI values between the novel strains were 94.37% (S1T-S2T), 95.03% (S2T-S5T), and 94.71% (S1T-S5T). All strains had C20:1 ω9c and summed feature 8 (C18:1 ω7c and/or C18:1 ω6c) as major cellular fatty acids. Additionally, diphosphatidylglycerol (DPG) and hydroxyphosphatidylethanolamine (OH-PE) were identified as major polar lipids. Menaquinone was undetected in all strains. The results from the phylogenetic, phenotypic, chemotaxonomic, and genotypic analyses collectively indicated that strains S1T, S2T, and S5T represent three distinct novel species within the genus Streptococcus, and we propose the names Streptococcus dentalis sp. nov. for strain S1T (= KCTC 21234T = JCM 36526T), Streptococcus gingivalis sp. nov. for strain S2T (= KCTC 21235T = JCM 36527T), and Streptococcus lingualis sp. nov. for strain S5T (= KCTC 21236T = JCM 36528T).

Citations

Citations to this article as recorded by  
  • Validation List no. 223. Valid publication of new names and new combinations effectively published outside the IJSEM
    Aharon Oren, Markus Göker
    International Journal of Systematic and Evolutionary Microbiology .2025;[Epub]     CrossRef
Review
The Microbiome Matters: Its Impact on Cancer Development and Therapeutic Responses
In‑Young Chung, Jihyun Kim, Ara Koh
J. Microbiol. 2024;62(3):137-152.   Published online April 8, 2024
DOI: https://doi.org/10.1007/s12275-024-00110-7
  • 386 View
  • 22 Download
  • 4 Web of Science
  • 6 Crossref
AbstractAbstract PDF
In the evolving landscape of cancer research, the human microbiome emerges as a pivotal determinant reshaping our understanding of tumorigenesis and therapeutic responses. Advanced sequencing technologies have uncovered a vibrant microbial community not confned to the gut but thriving within tumor tissues. Comprising bacteria, viruses, and fungi, this diverse microbiota displays distinct signatures across various cancers, with most research primarily focusing on bacteria. The correlations between specifc microbial taxa within diferent cancer types underscore their pivotal roles in driving tumorigenesis and infuencing therapeutic responses, particularly in chemotherapy and immunotherapy. This review amalgamates recent discoveries, emphasizing the translocation of the oral microbiome to the gut as a potential marker for microbiome dysbiosis across diverse cancer types and delves into potential mechanisms contributing to cancer promotion. Furthermore, it highlights the adverse efects of the microbiome on cancer development while exploring its potential in fortifying strategies for cancer prevention and treatment.

Citations

Citations to this article as recorded by  
  • Molecular mimicry as a driver of T cell-mediated tumour immunity
    Jamie Rossjohn, Luigi Nezi, Julianne S. Walz, Maria Tagliamonte, Luigi Buonaguro
    Trends in Immunology.2025;[Epub]     CrossRef
  • A Comprehensive Oncological Biomarker Framework Guiding Precision Medicine
    Reza Bayat Mokhtari, Manpreet Sambi, Faezeh Shekari, Kosar Satari, Roya Ghafoury, Neda Ashayeri, Paige Eversole, Narges Baluch, William W. Harless, Lucia Anna Muscarella, Herman Yeger, Bikul Das, Myron R. Szewczuk, Sayan Chakraborty
    Biomolecules.2025; 15(9): 1304.     CrossRef
  • COVID-19, Long COVID, and Gastrointestinal Neoplasms: Exploring the Impact of Gut Microbiota and Oncogenic Interactions
    do Rêgo Amália Cinthia Meneses, Araújo-Filho Irami
    Archives of Cancer Science and Therapy.2024; 8(1): 054.     CrossRef
  • Glycans in the oral bacteria and fungi: Shaping host-microbe interactions and human health
    Xiameng Ren, Min Wang, Jiabao Du, Yu Dai, Liuyi Dang, Zheng Li, Jian Shu
    International Journal of Biological Macromolecules.2024; 282: 136932.     CrossRef
  • A Review of the Relationship between Tumors of the Biliary System and Intestinal Microorganisms
    勇利 李
    Advances in Clinical Medicine.2024; 14(07): 833.     CrossRef
  • Host-Associated Microbiome
    Woo Jun Sul
    Journal of Microbiology.2024; 62(3): 135.     CrossRef

Journal of Microbiology : Journal of Microbiology
TOP